PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 223 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,599,000 | -12.0% | 150,751 | -1.2% | 1.60% | -21.4% |
| Q3 2019 | $4,091,000 | -2.3% | 152,551 | -1.2% | 2.03% | +0.9% |
| Q2 2019 | $4,187,000 | -24.2% | 154,351 | -3.0% | 2.01% | -24.1% |
| Q1 2019 | $5,523,000 | +71.8% | 159,172 | -3.3% | 2.65% | +55.3% |
| Q4 2018 | $3,214,000 | -34.6% | 164,672 | -10.8% | 1.71% | -12.7% |
| Q3 2018 | $4,917,000 | -17.3% | 184,672 | +17.3% | 1.96% | -17.1% |
| Q2 2018 | $5,948,000 | +14.8% | 157,480 | -0.7% | 2.36% | +21.8% |
| Q1 2018 | $5,179,000 | -31.6% | 158,580 | +1.9% | 1.94% | -29.3% |
| Q4 2017 | $7,573,000 | -2.5% | 155,580 | +8.2% | 2.74% | -12.4% |
| Q3 2017 | $7,765,000 | -5.2% | 143,730 | -1.4% | 3.13% | -10.7% |
| Q2 2017 | $8,187,000 | +7.5% | 145,755 | -25.0% | 3.51% | +2.5% |
| Q1 2017 | $7,617,000 | +46.2% | 194,380 | -16.3% | 3.42% | +41.0% |
| Q4 2016 | $5,211,000 | +24.6% | 232,230 | +26.1% | 2.43% | +88.0% |
| Q3 2016 | $4,181,000 | -14.2% | 184,130 | -10.8% | 1.29% | -47.1% |
| Q2 2016 | $4,874,000 | +57.5% | 206,530 | +36.2% | 2.44% | +62.9% |
| Q1 2016 | $3,094,000 | -61.7% | 151,680 | -3.5% | 1.50% | -53.1% |
| Q4 2015 | $8,086,000 | +20.1% | 157,180 | -0.5% | 3.19% | +18.9% |
| Q3 2015 | $6,730,000 | -5.3% | 157,930 | +1.9% | 2.69% | +11.7% |
| Q2 2015 | $7,108,000 | +25.1% | 155,030 | +3.6% | 2.40% | +15.2% |
| Q1 2015 | $5,681,000 | +46.8% | 149,680 | +9.6% | 2.09% | +40.8% |
| Q4 2014 | $3,869,000 | +43.0% | 136,630 | +27.7% | 1.48% | +39.8% |
| Q3 2014 | $2,705,000 | -13.4% | 107,030 | 0.0% | 1.06% | -5.0% |
| Q2 2014 | $3,123,000 | +12.8% | 107,030 | +0.1% | 1.12% | +1.2% |
| Q1 2014 | $2,769,000 | +147.9% | 106,930 | +146.4% | 1.10% | +139.5% |
| Q4 2013 | $1,117,000 | – | 43,400 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |